Overview

Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
0
Participant gender:
All
Summary
Study to compare of two contrast agents in imaging brain lesions.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Bayer
Criteria
Inclusion Criteria:

- Known neoplastic CNS lesions